The executive leadership team at Precision BioSciences includes Michael Amoroso serving as President and Chief Executive Officer, John Kelly as Chief Operating Officer, Dario Scimeca as Chief Legal Officer, and co-founder Jefferson Smith as Chief Research Officer, alongside other specialized senior vice presidents and scientific officers guiding the company's clinical development and corporate strategy.
Legendary investor Warren Buffett, through his conglomerate Berkshire Hathaway, famously invests in ordinary common shares of The Coca-Cola Company (ticker symbol KO). This iconic, long-term equity holding has remained a cornerstone of Berkshire Hathaway's public investment portfolio for decades, valued for the beverage giant's enduring global brand strength, durable competitive advantages, consistent pricing power, and reliable dividend distributions.